Going Green: The Complexities Of The Green Nail Syndrome

AAD Welcome!

Membership

• Account
• Pay dues
• Member ID
• Join the AAD
• Member benefits
• Find a member
• AAD governance
• Support AAD
• Community Programs
• AAD Help Center

• Apply for membership
• Reinstate membership

• Learn about benefits
• Dialogues in Dermatology
• AAD’s Brand Promise
• AAD Fellow logo
• Clinical Community
• Preferred providers
• Residents Resource Center

• Member directory
• Find a Dermatologist

• Strategic plan
• Bylaws, policies, & positions
• Board of Directors
• AAD Election
• Council, Committees, and Task Forces
• Executive staff
• Advisory Board
• Financial statement

• What we do
• Volunteer opportunities
• Annual fund
• Monthly giving
• Tribute
• Planned giving
• Our donors
• Donor Societies
• Corporate partners

• SPOT Skin Cancer™
• Camp Discovery
• Good Skin Knowledge
• Shade Structures
• Skin Cancer, Take a Hike!™
• Pathways: Inclusivity in Dermatology
• Resident Education Grants
• AAD Teledermatology
• Leadership Institute

Featured

Find a Dermatologist

Review your profile in our search tool for the public, which helps patients find board-certified dermatologists.

Member directory

Make sure your contact info is up to date in our directory. This listing is for AAD members only.

Meetings & Education

• 2026 Annual Meeting
• 2026 Innovation Academy
• Academy meetings archive
• Professional education
• Claim CME & view transcript
• Upcoming events
• Residents & medical students
• Patient education materials

• Registration
• Housing
• Education & program
• Faculty & abstracts
• Exhibit hall, networking & special events
• Meeting app
• FAQs
• For exhibitors, advertisers, sponsors & media

• Education & program
• Faculty & abstracts

• Claim CME
• Certificate of meeting attendance
• Session handouts

• Learning Center
• Question of the week
• JAAD quizzes
• Dialogues in Dermatology
• Hands-on at Home

• Career Launch Boot Camp: On-Demand
• DermCatalyst
• Legislative Conference
• Academy meeting locations and dates
• Board of Directors meetings
• Direct a meeting session
• Event calendar

• Boards Fodder archive
• Race for the case
• Board Prep Plus
• JAAD quizzes
• Directions in Residency
• Medical student resources
• Basic Dermatology Curriculum
• Basement Membrane Zone

Featured

AAD Learning Center

Explore the Academy's new and improved Learning Center, with enhanced ease of use for the education you trust.

2026 AAD Annual Meeting

Expand your education and connect with peers at the 2026 AAD Annual Meeting.

Practice management

• DataDerm
• Coding Resource Center
• MIPS & fee schedule
• Teledermatology
• EHR & health tech
• Insurance & drugs
• Compliance & practice scope
• Managing your practice
• Contact PM staff

• About DataDerm
• DataDerm Dashboard
• DataDerm Help Center
• Data request
• Enroll
• MIPS & fee schedule

• ICD-10-CM
• E/M
• Surgical & procedural
• Modifiers
• Audits
• Quick coding guides
• Derm Coding Consult
• Coding webinars
• Coding products

• 2025 MIPS reporting guide
• 2026 quality measures
• 2025 quality measures
• 2025 MIPS categories
• Medicare fee schedule

• EHR resources
• Health tech resources

• Prior authorization
• Private payer
• Lidocaine
• Drug pricing resources
• Compounding toolkit
• Step therapy laws

• Tools
• CLIA
• HIPAA
• iPLEDGE
• OSHA
• ADA
• Workplace Safety
• NP/PA laws
• Truth in advertising laws
• Compliance products

• Office optimization
• Staffing
• Buying or selling a practice
• Post a job
• Burnout & wellness
• Promote your practice
• AAD preferred vendors & discounts
• Practice management products
• Webinars

Featured

Need coding help?

Find practical guidance on coding issues common in dermatology practices.

Reduce burdens

Learn how to reduce burdens with health tech.

Clinical & quality

• Clinical guidelines
• Quality measures
• DataDerm
• Quality & patient safety
• Clinical Community
• Clinical care resources
• Position statements

• Acne
• Actinic Keratosis
• Atopic dermatitis
• Melanoma
• Basal cell carcinoma
• Cutaneous squamous cell carcinoma
• Office-based surgery
• Psoriasis

• MIPS measures
• Quality measures tool
• Learn about AAD measures
• Why use AAD measures for MIPS

• Access your account
• Enroll
• FAQs

• DW Insights & Inquiries
• Emerging diseases
• Clinical image collection
• Human trafficking
• Burden of Skin Disease
• Clinical apps
• Boards fodder archive
• Choosing Wisely
• Appropriate use

Featured

Clinical guidelines

Review current clinical guidelines, those in development, and guidelines that the AAD has collaborated on.

Why use AAD measures?

The Academy has developed quality measures to help your dermatology practice.

Publications & apps

• JAAD
• JAAD International
• JAAD Case Reports
• Dermatology World
• DermWorld Insights & Inquiries
• Derm Coding Consult
• DermWorld Meeting News
• Impact Report
• Other publications
• Academy Apps

• Dermatology Daily
• DermWorld Academy Insider
• DermWorld Weekly
• DermWorld Directions in Residency

• Academy Meeting app
• Learning Center app
• Dialogues in Dermatology app
• Mohs app

Featured

Latest news

Read this month's top stories in Dermatology World.

New insights

Check out DermWorld Insights & Inquiries for the latest updates from Dr. Warren Heymann

Career development

• Career launch
• Job board
• Burnout & wellness
• Diversity
• Awards, grants, and scholarships
• Leadership Institute
• Volunteer opportunities
• Ethics & professionalism

• Leadership Forum
• Academic Dermatology Leadership Program
• Advanced Leadership Forum
• Mentorship
• Learning resources

Featured

Physician wellness

Access tools and guidance on combatting burnout and fostering wellness.

Joining or selling a practice?

Get help to evaluate what practice type fits your needs, as well as guidance on selling a practice.

Advocacy

• Take action
• Advocacy priorities
• State advocacy resources
• Legislative Conference
• Position statements
• Promote the specialty
• Key Contacts
• Patient advocate resources
• SkinPAC
• Advocacy Update

• Medicare physician payment
• Drug access & affordability
• Sunscreen access
• Indoor tanning
• Payer advocacy
• Scope-of-practice
• Truth in advertising
• Medical research funding
• Teledermatology
• Medical liability protections

• Find your state society
• State advocacy grants
• Step therapy legislation
• Pending state legislation
• State society resources
• Advocate of the Year award

• Social media
• Your Dermatologist Knows
• SkinSerious
• What is a dermatologist
• How to select a dermatologist
• UV awareness

Featured

Promote the specialty

Access resources to help you promote the specialty in your community and beyond.

Advocacy priorities

Learn about the Academy's advocacy priorities and how to join efforts to protect your practice.

1. DW Insights and Inquiries
2. 2021 Archive

Advertisement Advertisement Going green: The complexities of the green nail syndrome

By Warren R. Heymann, MD February 3, 2021 Vol. 3, No. 5

I find a unique satisfaction in diagnosing the green nail syndrome (GNS, aka chloronychia, Goldman-Fox syndrome) — it is easy to recognize and very reassuring to patients who were convinced they had a subungual melanoma. Based on new data, my concern (therefore my patients’ problem) is that the instantaneous diagnosis may have occasionally obviated further scrutiny of their nail disorder(s).

GNS has been described as a triad of green discoloration of the nail plate, proximal paronychia, and distal onycholysis. The color of the nail may vary from blue-green, to green-brown, or green-yellow. Usually only one or two nails are involved. GNS often is noted in patients with other nail disorders such as psoriasis or paronychia, especially in the context of a moist environment; this is particularly true for hairdressers, dishwashers, and medical personnel. The differential diagnosis includes oncychomycosis, subungal hematoma, or melanoma. (1)

Overwhelmingly, Pseudomonas aeruginosa (a Gram-negative, aerobic coccobacillus) is the responsible bacterium causing GNS by producing pyoverdin and pyocyanin. (2) There is a fascinating reciprocal relationship between P. aeruginosa and fungi or yeast. P. aeruginosa has antifungal activity because of its production of pyocyanin and 1‐hydroxyphenazine. Additionally, it has been demonstrated that P. aeruginosa forms a dense biofilm on C. albicans filaments thereby killing the yeast. (3) The bacterium has been shown to inhibit the growth of Trichophyton rubrum and T. mentagrophytes. (4) Alternatively, dermatophytosis predisposes to infections by P. aeruginosa; it has been isolated from 7% of all clinically suspected cases of onychomycosis, and from 14% of mycologically confirmed onychomycosis cases using calcofluor/KOH. (5) Onychomycotic nails may provide an environment suitable for prolonged carriage of P. aeruginosa because nail spaces created beneath the lateral folds are ideal for their growth. (3)

Surprisingly, there have been remarkably few studies defining the relationship of GNS with onychomycosis. Ohn et al performed a retrospective study of 23 cases of GNS in which clippings utilizing PAS or GMS stains were performed. Five patients (21.7%) had immunosuppressive conditions including internal malignancies, autoimmune disorders, and diabetes mellitus. A previous history of nail diseases was reported in 13 cases (56.5%), including 12 patients with a history of onychomycosis and 1 patient with nail psoriasis. Of affected nails, 18 (78.3%) were toenails and 5 (21.7%) were fingernails. Involvement of the great toenail or thumbnail was found in 22 patients (95.7%). Fungal coinfection was noted in 15 patients (65.2%). The authors concluded that onychomycosis was frequently associated with GNS and might be a predisposing factor of GNS. They recommended that the nails in patients with GNS be carefully examined to detect possible fungal infections. (6)

Treatment begins with measures to keep the nails dry, avoiding wet work if possible. Briefly soaking the nail in a diluted sodium hypochlorite (bleach) solution also helps to suppress bacterial growth. (7) I often recommend diluted acetic acid (vinegar) soaks. Additionally, either topical or systemic antibiotics may be utilized. Bae et al report the successful treatment of GNS with tobramycin eye drops. (8) Fluoroquinolones such as ciprofloxacin or levofloxacin are regarded as first-line systemic treatment. (As per Epocrates, do not forget to inform patients of the black box warning regarding tendinitis/tendon rupture, peripheral neuropathy, and CNS effects that may occur during treatment or months after discontinuation of the drug!) Nail extraction may be required in refractory cases.

I started to turn green after thinking about how I may not have been managing GNS optimally. While straightforward, the disorder has levels of complexity that demand our attention. Whether it is diagnosing attendant onychomycosis or properly warning our patients of the risk of fluoroquinolones, there is much more to GNS than eradicating its color.

Point to Remember: The green nail syndrome requires a careful assessment to rule out and treat associated disorders (especially onychomycosis) in addition to eradicating Pseudomonas aeruginosa infection.

Our Expert’s Viewpoint

Richard K. Scher, MD Clinical Professor of Dermatology Weill Cornell Medicine/Dermatology

When I think of green, I think of St Patrick's Day, spring, and the green nail syndrome. An often overlooked onychodystrophy, frequently referred to as chloronychia or Goldman-Fox syndrome, with its bright green color, presents a plethora of pitfalls for the physician. The spectrum is wide from nail melanoma to infections like Pseudomonas, onychomycosis, and Candidiasis to troublesome subungual hematomas.

It behooves us to be alert to the fact that several complications may occur. The green nail with onycholysis and paronychia may be masking a melanoma that mandates a biopsy. The occurrence of Pseudomonas aeruginosa seduces the presence of fungal nail infections such as Trichophyton rubrum. As times one may accompany the other as a result of subungual nail unit spaces.

After correct diagnoses have been established — preceded by necessary studies — then a range of therapies are available which include avoidance of moisture, topical acetic acid/hypochlorite soaks, antibiotics, and others. Finally, health care workers and the elderly are prone. Don’t go red, go green.

Dr. Scher had disclosed financial relationships with the following to the AAD at the time of publication: MOE Medical Devices LLC. Full disclosure information is available.

1. Schwartz RA, Reynoso-Vasquez N, Kapila R. Chloronychia: The Goldman-Fox syndrome – implications for patients and healthcare workers. Indian J Dermatol 2020; 65: 1-4.

2. Chiriac A, Brzezinski P, Foia L, Marincu L. Chloronychia: Green nail syndrome caused by Pseudomonas aeruginosa in elderly persons. Clin Interv Aging 2015; 10: 265-267.

3. Yang YS, Ahn JJ, Shin MK, Lee MH. Fusarium solani onychomycosis of the thumbnail coinfected with Psuedomonas aeruginosa: Report of two cases. Mycoses 2011; 54: 168-171

4. Treat J, James WD, Nachamkin I, Seykora J. Growth inhibition of Trichophyton species by Pseudomonas aeruginosa. Arch Dermatol 2007; 143: 61-64.

5. Thomas LM, Elewski B. The presence of Pseudomonas aeruginosa in clinically suspected dermatophyte onychomycosis. J Am Acad Dermatol 2004; 50S: 90.

6. Ohn J, Yu DA, Park H, Cho S, Mun JH. Green nail syndrome: Analysis of the association with onychomycosis. J Am Acad Dermatol 2020; Jan 28 [Epub ahead of print].

7. Gish D, Romero BJ. Green fingernail. J Fam Pract 2017; 66: e7-e9.

8. Bae Y, Lee GM, Sim JH, Lee S, et al. Green nail syndrome treated with the application of tobramycin eye drop. Ann Dermatol 2014 Aug; 26(4): 514–516.

All content found on Dermatology World Insights and Inquiries, including: text, images, video, audio, or other formats, were created for informational purposes only. The content represents the opinions of the authors and should not be interpreted as the official AAD position on any topic addressed. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

DW Insights and Inquiries archive

Explore hundreds of Dermatology World Insights and Inquiries articles by clinical area, specific condition, or medical journal source.

Access archive

Advertisement

The American Academy of Dermatology is a non-profit professional organization and does not endorse companies or products. Advertising helps support our mission.

Opportunities

Advertising | Sponsorship

Advertisement Advertisement

Registration begins today at 12 pm noon (CT) for physician members, life members, and honorary members.

Go to registration and housing system No thanks, I'll do this later Advertisement